[1] Sung H,Ferlay J,Siegel R L,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249. [2] Llovet J M,Brú C,Bruix J.Prognosis of hepatocellular carcinoma:The BCLC staging classification[J].Semin Liver Dis,1999,19(3):329-338. [3] Chan Y T,Zhang C,Wu J,et al.Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma[J].Mol Cancer,2024,23(1):189. [4] Dhanasekaran R,Deutzmann A,Mahauad-Fernandez W D,et al.The MYC oncogene-the grand orchestrator of cancer growth and immune evasion[J].Nat Rev Clin Oncol,2022,19(1):23-36. [5] Moon H,Park H,Ro S W.c-Myc-driven hepatocarcinogenesis[J].Anticancer Res,2021,41(10):4937-4946. [6] Zhou J N,Zhang B,Wang H Y,et al.A functional screening identifies a new organic selenium compound targeting cancer stem cells:Role of c-Myc transcription activity inhibition in liver cancer[J].Adv Sci(Weinh),2022,9(22):e2201166. [7] Hasakova K,Vician M,Reis R,et al.The expression of clock genes Cry1 and Cry2 in human colorectal cancer and tumor adjacent tissues correlates differently dependent on tumor location[J].Neoplasma,2018,65(6):986-992. [8] Mazzoccoli G,Colangelo T,Panza A,et al.Deregulated expression of cryptochrome genes in human colorectal cancer[J].Mol Cancer,2016,15:6. [9] 李超,袁鹏,颜昭勇,等.CRY2分子对肝癌细胞生长和转移的影响[J].现代生物医学进展,2017,17(36):7030-7035,7084. Li C,Yuan P,Yan Z Y,et al.Effects of CRY2 on the growth and metastasis of hepatocellular carcinoma cells[J].Progress in Modern Biomedicine,2017,17(36):7030-7035,7084. [10] Zhang Z,Liang Z,Gao W,et al.Identification of circadian clock genes as regulators of immune infiltration in hepatocellular carcinoma[J].J Cancer,2022,13(11):3199-3208. [11] Huber A L,Papp S J,Chan A B,et al.CRY2 and FBXL3 cooperatively degrade c-Myc[J].Mol Cell,2016,64(4):774-789. [12] Huyen V T,Echizen K,Yamagishi R,et al.Regular exercise suppresses steatosis-associated liver cancer development by degrading E2F1 and c-Myc via circadian gene upregulation[J].Genes Cells,2024,29(11):1012-1025. [13] Lin M,Fang Z,Lin X,et al.TRIM55 inhibits colorectal cancer development via enhancing protein degradation of c-Myc[J].Cancer Med,2023,12(12):13511-13521. [14] Lin C,Feng S,DeOliveira C C,et al.Cryptochrome-timeless structure reveals circadian clock timing mechanisms[J].Nature,2023,617(7959):194-199. [15] Xia K,Li S,Yang Y,et al.Cryptochrome 2 acetylation attenuates its antiproliferative effect in breast cancer[J].Cell Death Dis,2023,14(4):250. [16] Yu Y,Li Y,Zhou L,et al.Cryptochrome 2(CRY2)suppresses proliferation and migration and regulates clock gene network in osteosarcoma cells[J].Med Sci Monit,2018,24:3856-3862. [17] Huisman S A,Ahmadi A R,Ijzermans J N M,et al.Disruption of clock gene expression in human colorectal liver metastases[J].Tumour Biol,2016,37(10):13973-13981. [18] 许静,孙诚谊,喻超,等.CRY2过表达对肝癌细胞增殖及生物钟基因、蛋白表达的影响[J].山东医药,2019,59(8):5-8. Xu J,Sun C Y,Yu C,et al.Effects of CRY2 overexpression on cell proliferation,clock gene and protein expression of hepatocellular carcinoma cells[J].Shandong Medical Journal,2019,59(8):5-8. [19] Zhang Z,Liang Z,Gao W,et al.Identification of circadian clock genes as regulators of immune infiltration in hepatocellular carcinoma[J].J Cancer,2022,13(11):3199-3208. [20] Land H,Parada L F,Weinberg R A.Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes[J].Nature,1983,304(5927):596-602. [21] Zhu Y,Zhou B,Hu X,et al.LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability[J].Clin Transl Med,2022,12(1):e703. [22] Mastronikolis N,Ragos V,Kyrodimos E,et al.Mechanisms of c-Myc oncogenic activity in head and neck squamous cell carcinoma[J].J BUON,2019,24(6):2242-2244. [23] Cao Z,Jing Y,Cheng C,et al.EIF2Ss,a novel c-Myc-correlated gene family,is associated with poor prognosis and immune infiltration in pancreatic adenocarcinoma[J].Front Biosci(Landmark Ed),2024,29(3):119. [24] Hoffman B,Liebermann D A.Apoptotic signaling by c-Myc[J].Oncogene,2008,27(50):6462-6472. [25] Chan A B,Parico G C G,Fribourgh J L,et al.Cry2 missense mutations suppress P53 and enhance cell growth[J].Proc Natl Acad Sci U S A,2021,118(27):e2101416118. [26] Wu L,Cheng B,Liu Q,et al.Cry2 suppresses trophoblast migration and invasion in recurrent spontaneous abortion[J].J Biochem,2020,167(1):79-87. [27] 赵行宇,杨昆,宋梓桐,等.胡桃醌通过促进c-Myc泛素化降解抑制宫颈癌细胞的生长和促进凋亡[J].南方医科大学学报,2022,42(7):1026-1031. Zhao X Y,Yang K,Song Z T,et al.Juglone induces proliferation inhibition and apoptosis of cervical cancer cells via promoting c-Myc ubiquitination[J].Journal of Southern Medical University,2022,42(7):1026-1031. [28] Dhanasekaran R,Park J,Yevtodiyenko A,et al.Myc ASO impedes tumorigenesis and elicits oncogene addiction in autochthonous transgenic mouse models of HCC and RCC[J].Mol Ther Nucleic Acids,2020,21:850-859. [29] Lin C J,Nasr Z,Premsrirut P K,et al.Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis[J].Cell Rep,2012,1(4):325-333. [30] Wang H,Yang W,Qin Q,et al.E3 ubiquitin ligase MAGI3 degrades c-Myc and acts as a predictor for chemotherapy response in colorectal cancer[J].Mol Cancer,2022,21(1):151. [31] Chen S,Zhao L,Liu J,et al.Inhibition of KIF20A enhances the immunotherapeutic effect of hepatocellular carcinoma by enhancing c-Myc ubiquitination[J].Cancer Lett,2024,598:217105. [32] Huber A L,Papp S J,Chan A B,et al.Cry2 and FBXL3 cooperatively degrade c-Myc[J].Mol Cell,2016,64(4):774-789. [33] Guo J,Hao J,Jiang H,et al.Proteasome activator subunit 3 promotes pancreatic cancer growth via c-Myc-glycolysis signaling axis[J].Cancer Lett,2017,386:161-167. [34] Wang J,Yang Y,Shao F,et al.Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc[J].Nat Metab,2024,6(5):914-932. |